Forward signals for 2026—from >$1.3B in tracked financings led by Neuralink’s $650M round to a shoebox-sized biocomputer, driven device control, speech restoration, and early clinical proof points
Thanks, Tatyana, a great pick! It seems like a promising development with major potential! I hope it goes beyond preclinical very soon, because to me, the key here is a non-surgical way of administration. This can open doors to a truly wide-scale adoption if clinical studies succeed. I think the company behind the commercialization effort is Cahira Technologies, a spin-off from MIT, right? Certainly an interesting startup to track...
Yes that’s what I have gathered. The lead researcher is the founder of Cahira Technologies. I agree. I don’t think a craniotomy was ever going to land at scale for patients or consumers. Hopeful and excited to see how this progresses!
Love this piece—thank you for compiling a 2025 recap! Have you seen the news of Circulatronics out of MIT?
https://m.youtube.com/watch?v=dDcgLM6Glg4
Thanks, Tatyana, a great pick! It seems like a promising development with major potential! I hope it goes beyond preclinical very soon, because to me, the key here is a non-surgical way of administration. This can open doors to a truly wide-scale adoption if clinical studies succeed. I think the company behind the commercialization effort is Cahira Technologies, a spin-off from MIT, right? Certainly an interesting startup to track...
Yes that’s what I have gathered. The lead researcher is the founder of Cahira Technologies. I agree. I don’t think a craniotomy was ever going to land at scale for patients or consumers. Hopeful and excited to see how this progresses!
Same!